| Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances I Wiegand, K Hilpert, REW Hancock Nature protocols 3 (2), 163-175, 2008 | 5735 | 2008 |
| Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen CK Stover, XQ Pham, AL Erwin, SD Mizoguchi, P Warrener, MJ Hickey, ... Nature 406 (6799), 959-964, 2000 | 5479 | 2000 |
| Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies REW Hancock, HG Sahl Nature biotechnology 24 (12), 1551-1557, 2006 | 4453 | 2006 |
| Peptide antimicrobial agents H Jenssen, P Hamill, REW Hancock Clinical microbiology reviews 19 (3), 491-511, 2006 | 3168 | 2006 |
| Peptide antibiotics REW Hancock, DS Chapple Antimicrobial agents and chemotherapy 43 (6), 1317-1323, 1999 | 1968 | 1999 |
| Designing antimicrobial peptides: form follows function CD Fjell, JA Hiss, REW Hancock, G Schneider Nature reviews Drug discovery 11 (1), 37-51, 2012 | 1940 | 2012 |
| Cationic peptides: a new source of antibiotics REW Hancock, R Lehrer Trends in biotechnology 16 (2), 82-88, 1998 | 1923 | 1998 |
| Peptide antibiotics REW Hancock The lancet 349 (9049), 418-422, 1997 | 1766 | 1997 |
| The role of cationic antimicrobial peptides in innate host defences REW Hancock, G Diamond Trends in microbiology 8 (9), 402-410, 2000 | 1686 | 2000 |
| Pseudomonas aeruginosa : new insights into pathogenesis and host defenses SL Gellatly, REW Hancock Pathogens and disease 67 (3), 159-173, 2013 | 1463 | 2013 |
| Pseudomonas aeruginosa: all roads lead to resistance EBM Breidenstein, C de la Fuente-Núñez, REW Hancock Trends in microbiology 19 (8), 419-426, 2011 | 1385 | 2011 |
| Cationic peptides: effectors in innate immunity and novel antimicrobials REW Hancock The Lancet infectious diseases 1 (3), 156-164, 2001 | 1327 | 2001 |
| The role of antimicrobial peptides in animal defenses REW Hancock, MG Scott Proceedings of the national Academy of Sciences 97 (16), 8856-8861, 2000 | 1306 | 2000 |
| Antibacterial peptides for therapeutic use: obstacles and realistic outlook AK Marr, WJ Gooderham, REW Hancock Current opinion in pharmacology 6 (5), 468-472, 2006 | 1286 | 2006 |
| NetworkAnalyst 3.0: a visual analytics platform for comprehensive gene expression profiling and meta-analysis G Zhou, O Soufan, J Ewald, REW Hancock, N Basu, J Xia Nucleic acids research 47 (W1), W234-W241, 2019 | 1210 | 2019 |
| The relationship between peptide structure and antibacterial activity JPS Powers, REW Hancock Peptides 24 (11), 1681-1691, 2003 | 1180 | 2003 |
| InnateDB: systems biology of innate immunity and beyond—recent updates and continuing curation K Breuer, AK Foroushani, MR Laird, C Chen, A Sribnaia, R Lo, GL Winsor, ... Nucleic acids research 41 (D1), D1228-D1233, 2013 | 1140 | 2013 |
| Cationic host defense (antimicrobial) peptides KL Brown, REW Hancock Current opinion in immunology 18 (1), 24-30, 2006 | 1035 | 2006 |
| Resistance Mechanisms in Pseudomonas aeruginosa and Other Nonfermentative Gram-Negative Bacteria REW Hancock Clinical Infectious Diseases 27 (Supplement_1), S93-S99, 1998 | 988 | 1998 |
| Adaptive and mutational resistance: role of porins and efflux pumps in drug resistance L Fernández, REW Hancock Clinical microbiology reviews 25 (4), 661-681, 2012 | 973 | 2012 |
Susan FarmerResearch Associate, Department of Microbiology and Immunology, University of British ColumbiaVerified email at mail.ubc.ca
